Newport Trust Company
ELV icon

Newport Trust Company’s Elevance Health ELV Stock Holding History

Newport Trust Company’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$369M Sell
954,915
-30,273
-3% -$11.2M 0.89% 22
2026
Q1 		$288M Sell
985,188
-19,832
-2% -$6.52M 0.71% 24
2025
Q4 		$352M Sell
1,005,020
-18,997
-2% -$6.42M 0.84% 22
2025
Q3 		$331M Sell
1,024,017
-22,027
-2% -$6.85M 0.75% 23
2025
Q2 		$407M Sell
1,046,044
-21,024
-2% -$8.46M 0.98% 21
2025
Q1 		$464M Sell
1,067,068
-39,045
-4% -$15.7M 1.19% 16
2024
Q4 		$408M Sell
1,106,113
-22,293
-2% -$9.33M 0.99% 19
2024
Q3 		$587M Sell
1,128,406
-17,362
-2% -$9.28M 1.42% 13
2024
Q2 		$621M Sell
1,145,768
-33,408
-3% -$17.7M 1.56% 13
2024
Q1 		$611M Sell
1,179,176
-31,343
-3% -$15.6M 1.66% 12
2023
Q4 		$571M Sell
1,210,519
-31,119
-3% -$14.4M 1.52% 13
2023
Q3 		$541M Sell
1,241,638
-21,002
-2% -$9.53M 1.66% 13
2023
Q2 		$561M Sell
1,262,640
-17,265
-1% -$7.96M 1.64% 12
2023
Q1 		$589M Sell
1,279,905
-10,355
-0.8% -$4.93M 1.63% 13
2022
Q4 		$662M Sell
1,290,260
-16,089
-1% -$8.17M 1.84% 12
2022
Q3 		$593M Sell
1,306,349
-19,717
-1% -$9.43M 2.01% 12
2022
Q2 		$640M Sell
1,326,066
-16,742
-1% -$8.28M 2.07% 11
2022
Q1 		$660M Sell
1,342,808
-13,459
-1% -$6.15M 1.85% 10
2021
Q4 		$629M Sell
1,356,267
-18,712
-1% -$7.87M 1.7% 11
2021
Q3 		$513M Sell
1,374,979
-21,789
-2% -$8.28M 1.39% 11
2021
Q2 		$533M Sell
1,396,768
-31,492
-2% -$12M 1.35% 11
2021
Q1 		$513M Sell
1,428,260
-42,872
-3% -$13.8M 1.28% 11
2020
Q4 		$472M Buy
+1,471,132
New +$451M 1.3% 11

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Newport Trust Company's ELV Position: Q2 2026 in Review

Newport Trust Company reduced its Elevance Health (ELV) stake by 3.1% in Q2 2026, selling an estimated $11.2M and leaving 954,915 shares worth $369M. The position accounts for 0.89% of the portfolio, ranked #22.

Newport Trust Company first reported a position in ELV in Q4 2020 and has held it in 23 quarters since. The position peaked at $662M in Q4 2022. 1,600 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Newport Trust Company held 954,915 shares of Elevance Health worth $369M as of Q2 2026.
  • Newport Trust Company sold 30,273 Elevance Health shares in Q2 2026, an estimated $11.2M.
  • Elevance Health made up 0.89% of Newport Trust Company's portfolio in Q2 2026, its #22 holding.
  • Newport Trust Company first reported a position in Elevance Health in Q4 2020 and has held it in 23 quarters since.
  • Newport Trust Company's Elevance Health position peaked at $662M in Q4 2022.
  • 1,600 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Newport Trust Company's 13F filing for Q2 2026, filed 13 Aug 2026.